Grossman Adam S sold ADMA
October 24, 2025 · Form 4 insider transaction
Grossman Adam S sold 15,000 shares of ADMA Biologics, Inc. at $16.00 per share, a transaction worth $240.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
15,000
Price
$16.00
Total value
$240.0K
InsiderGrossman Adam S
RoleOfficer, Director
CompanyADMA Biologics, Inc. (ADMA)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 24, 2025
Filing dateOctober 24, 2025
Shares owned after2,025,850
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction was effected pursuant to a Rule 10b5-1 trading plan entered into between the reporting person and Fidelity Brokerage Services LLC on December 5, 2024, as previously disclosed by the issuer.; The price reported in Column 4 is the price at which the shares were sold.